Top Suppliers:I want be here
  • DC Chemicals Limited
  • China
  • Product Name: Droxicam
  • Price: $Inquiry/100mg $Inquiry/250mg $Inquiry/500mg
  • Purity: 98.0%
  • Stocking Period: 3 Day
  • Contact: Tony Cao

90101-16-9

90101-16-9 structure
90101-16-9 structure

Name droxicam
Synonyms Droxicam
2H,5H-1,3-Oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide
5-methyl-6,6-dioxo-3-pyridin-2-yl-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4-dione
5-Methyl-3-(2-pyridinyl)-2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide
5-Methyl-3-(pyridin-2-yl)-2H,5H-[1,3]oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-dioxide
Ombolan
5-Methyl-3-(2-pyridinyl)-2H,5H-1,3-oxazino[5,6-c][1,2]benzothiazine-2,4(3H)-dione 6,6-Dioxide
5-Methyl-3-(pyridin-2-yl)benzo[5,6][1,2]thiazino[3,4-e][1,3]oxazine-2,4(3H,5H)-dione 6,6-dioxide
Description Droxicam (Ombolan) is a non-steroidal anti-inflammatory agent, with strong analgesic activity. Droxicam acts by inhibiting PGE2 varies, and is characterised by being a pro-drug of Piroxicam (HY-B0253). Droxicam is well tolerated with slight side effects in the said mucosa. Droxicam does not show cardiovascular or respiratory effects in cats, and inhibits peritoneal capillary permeability in mouse[1][2].
Related Catalog
In Vivo Droxicam (0.25 和 0.5 mg/kg;口服) 在角叉菜胶诱导的大鼠水肿中表现出高抗炎活性[1]。 Droxicam (ED50, p.o.; 5, 6, 7, 8 h; 7.5, 12.9, 4.8, 8.4 mg/kg) 在大鼠中对制霉菌素诱导的水肿表现出高抗炎活性[1]。 Droxicam (ED50,口服,1、2、3、4 小时:0.51、0.94、1.56、4.88 mg/kg) 对紫外线光诱导红斑的豚鼠,显示出保护作用[1]。 Droxicam (0.1 mg/kg, 0.33 mg/kg, 1 mg/kg; po; 每日一次) 在注射 Mycobacterium butyricum 的大鼠中显示出良好的抗关节炎活性,可抵抗原发性和继发性病变[1]。 Droxicam 在防止小鼠扭体方面表现出很强的镇痛活性,对由苯基苯醌诱导、乙酰胆碱溴化物诱导的小鼠,ED50 分别为 5.3 mg/kg 和 1.1 mg/kg[1]。 Droxicam (ED50=0.081 mg/kg; po) 保护大鼠免受蓖麻油引起的腹泻[1]。 Droxicam 显著抑制小鼠腹膜毛细血管通透性[1]。 Droxicam 在 Irwin 试验中,不会改变大鼠的行为 (80 mg/kg,i.p.) 和小鼠的行为 (160 mg/kg,p.o.)[1]。 Droxicam 在大鼠中不表现出排尿酸活性,在麻醉猫中既不表现出心血管或呼吸作用,也不改变它们对乙酰胆碱、去甲肾上腺素和组胺给药的反应[1]。
References

[1]. Farré AJ, et al. Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent. Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22.  

[2]. Jané F, et al. Droxicam: a pharmacological and clinical review of a new NSAID. Eur J Rheumatol Inflamm. 1991;11(4):3-9.  

Density 1.7±0.1 g/cm3
Boiling Point 554.7±60.0 °C at 760 mmHg
Melting Point 259-261°
Molecular Formula C16H11N3O5S
Molecular Weight 357.34
Flash Point 289.3±32.9 °C
Exact Mass 357.041931
PSA 110.86000
LogP 1.11
Vapour Pressure 0.0±1.5 mmHg at 25°C
Index of Refraction 1.748

CHEMICAL IDENTIFICATION

RTECS NUMBER :
RP6505000
CHEMICAL NAME :
2H,5H-1,3-Oxazino(5,6-c)(1,2)benzothiazine-2,4(3H)-di one, 5-methyl-3-(2-pyridinyl)-, 6,6-dioxide
CAS REGISTRY NUMBER :
90101-16-9
LAST UPDATED :
199612
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C16-H11-N3-O5-S
MOLECULAR WEIGHT :
357.36

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1434 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4563452
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
6192 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #4563452

~83%

90101-16-9 structure

90101-16-9

Literature: Bracher, Franz; Berns, Caroline Journal fur Praktische Chemie - Chemiker - Zeitung, 1997 , vol. 339, # 5 p. 477 - 478
Precursor  2

DownStream  0